For BRCA2, the estimated breast cancer RR (95% CI) increased to a maximum of 14.1 (10.3–19.4) in the 40–49 age group and decreased to 4.9 (1.5–15.7) in the 70–79 age group (p-value for trend = 0.06). This evidence concerns the gene BRCA2 and breast cancer.